America learned during the pandemic that it should never depend on our adversaries for our necessities. But if President ...

The EU pharmaceutical reform aims to improve drug accessibility, affordability, and innovation, addressing market protection and antimicrobial resistance. Co-legislators in Europe have reached a ...

FDA has given tentative approval to Lupin’s Siponimod tablets, a bioequivalent version of Mayzent, to treat people with ...

The Council and the Parliament have reached a deal on new rules to make the EU’s pharmaceutical sector fairer and more ...

Starting January 1, 2026, Mexico will impose tariffs of 5%–50% on 1,460 products from non-FTA countries, targeting cheap ...

In 2026, Novo Nordisk’s patent on semaglutide will expire in several countries, including India and China. Industry experts ...

The FDA’s effort to curb high drug costs by accelerating approvals of cheaper medicines similar to expensive biologics will ...

Democrats are riding high after special elections, but that doesn’t mean they’re popular. Strategist Simon Bazelon has advice ...

Formularies continue to increase in complexity, and changes to those formularies are especially challenging for consumers to navigate.

Across Ohio, researchers are achieving medical breakthroughs on what seems to be a monthly basis. Unfortunately, proposed legislation in Congress threatens to undermine Buckeye scientists by weakening ...

As a work of reportage, Off the Scales does a wonderful job of explaining the origins of Ozempic and other GLP-1 drugs and ...

New 2025 study results show Clascoterone, originally approved for acne, could be the first new effective topical for male ...